Drug apitegromab may stop muscle loss when taking weight loss drugs

A drug called apitegromab may help preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The findings suggest that blocking a protein that limits muscle growth may improve patient weight loss outcomes by reducing the loss of lean body mass.